A novel targeted multifunctional nanoplatform for visual chemo-hyperthermia synergy therapy on metastatic lymph nodes via lymphatic delivery.

Abstract

BACKGROUND:

Distant metastasis to vital organs is the major contributor to breast cancer mortality, and regional lymph node metastasis is an important facilitator of distant metastasis and recurrence in this cancer. The early diagnosis and precise treatment of lymph node metastasis are crucial for staging and prognosis in breast cancer. Herein, we report a visualized precision medicine nanoplatform of metastatic lymph nodes for ultrasonic/photoacoustic (US/PA) dual modal imaging-guided in situ targeted hyperthermia-combined chemotherapy.

RESULTS:

Carbon nanoparticles (CNs), approved by the China Food and Drug Administration, were loaded with docetaxel and rationally combined with anti-hypoxia-inducible factor 1α antibody-modified poly (lactic-co-glycolic acid) (PLGA) nanoparticles to achieve the combination of passive targeting at the lymph nodes and intracellular targeting at HIF 1α factor. The accumulation and retention of nanoparticles in metastatic lymph nodes via lymphatic delivery were enhanced. Docetaxel could be effectively offloaded by CNs that have active carbon nanoparticles, and the PLGA membrane prevented drug leakage. The nanoparticles exhibited excellent photothermal performance with a photothermal conversion efficiency of 28.9%, killing tumor cells in metastatic lymph nodes through hyperthermia. In vitro and in vivo systematic evaluations revealed that hyperpyrexia triggered the rupture of nanoparticles caused by the phase transition of perfluorohexane, resulting in docetaxel release for achieving in situ hyperthermia-combined chemotherapy.

CONCLUSIONS:

The laser-triggered highly efficient in situ chemotherapy nanosystem achieves targeted synergistic chemo-hyperthermia treatment of metastatic lymph nodes, and lymphatic delivery represents a strategy to avoid additional injury caused by drugs entering the blood circulation.

• Authors: Weiwei Liu, Xiaoping Ye, Lingyun He, Juan Cheng, Wenpei Luo, Min Zheng, Yaqin Hu, Wei Zhang, Yang Cao, Haitao Ran, Lu Yang
• Journal: Journal of nanobiotechnology (J Nanobiotechnology) Vol. 19 Issue 1 Pg. 432 (Dec 20 2021) ISSN: 1477-3155 [Electronic] England
• PMID: 34930301 (Publication Type: Journal Article)
• Copyright: © 2021. The Author(s).

Chemical References

• Antibodies
• Antineoplastic Agents
• Hypoxia-Inducible Factor 1, alpha Subunit
• Docetaxel
• Polylactic Acid-Polyglycolic Acid Copolymer
• Carbon

Topics

• Animals
• Antibodies (chemistry, immunology)
• Antineoplastic Agents (chemistry, metabolism, pharmacology, therapeutic use)
• Apoptosis (drug effects)
• Carbon (chemistry)
• Cell Line, Tumor
• Docetaxel (chemistry, metabolism, pharmacology, therapeutic use)
• Female
• Humans
• Hyperthermia, Induced (methods)
• Hypoxia-Inducible Factor 1, alpha Subunit (immunology, metabolism)
• Infrared Rays
• Lymph Nodes (metabolism)
• Lymphatic Metastasis
• Nanomedicine
• Nanoparticles (chemistry, metabolism)
• Neoplasms (drug therapy, pathology)
• Polylactic Acid-Polyglycolic Acid Copolymer (chemistry)
• Rats
• Transplantation, Heterologous